Literature DB >> 1445851

Interactions of retinol with binding proteins: studies with retinol-binding protein and with transthyretin.

N Noy1, E Slosberg, S Scarlata.   

Abstract

The interactions within the molecular complex in which retinol circulates in blood were studied. To monitor binding between retinol-binding protein (RBP) and transthyretin (TTR), TTR was labeled with a long-lived fluorescence probe (pyrene). Changes in the rotational volume of TTR following its association with RBP were monitored by fluorescence anisotropy of the probe. Titration of TTR with holo-RBP revealed the presence of 1.5 binding sites characterized by a dissociation constant Kd = 0.07 microM. At 0.15 M NaCl, binding of RBP to TTR showed an absolute requirement for the native ligand, retinol. At higher ionic strength (0.5 M NaCl), RBP complexed with retinal also bound to TTR with high affinity (Kd = 0.134 microM). RBP containing retinoic acid did not bind to TTR even at the high salt concentration. The data suggest that the TTR binding site on RBP is in close proximity to the retinoid binding site and that the head group of retinoic acid, when bound to RBP, presents steric hindrance for the interactions with TTR. The implications of the data for selectivity in retinoid transport in the circulation are discussed. The kinetics of the steps leading to complete dissociation of the retinol-RBP-TTR complex was also studied. The first step of this process was dissociation of retinol, which had a rate constant of 0.06/min. Following loss of retinol, the two proteins dissociate. The rate of dissociation is slow (k = 0.055/h), however, indicating that the complex apo-RBP-TTR will be an important factor in regulating serum levels of retinol.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445851     DOI: 10.1021/bi00160a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.

Authors:  Konstantin Petrukhin
Journal:  Drug Discov Today Ther Strateg       Date:  2013

Review 2.  STRA6: role in cellular retinol uptake and efflux.

Authors:  Mary Kelly; Johannes von Lintig
Journal:  Hepatobiliary Surg Nutr       Date:  2015-08       Impact factor: 7.293

Review 3.  Retinoic acid signaling pathways in development and diseases.

Authors:  Bhaskar C Das; Pritam Thapa; Radha Karki; Sasmita Das; Sweta Mahapatra; Ting-Chun Liu; Ingrid Torregroza; Darren P Wallace; Suman Kambhampati; Peter Van Veldhuizen; Amit Verma; Swapan K Ray; Todd Evans
Journal:  Bioorg Med Chem       Date:  2013-11-22       Impact factor: 3.641

4.  Binding of perlecan to transthyretin in vitro.

Authors:  S Smeland; S O Kolset; M Lyon; K R Norum; R Blomhoff
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

5.  Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro.

Authors:  J T White; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

Review 6.  Delivery of retinoid-based therapies to target tissues.

Authors:  Alexander R Moise; Noa Noy; Krzysztof Palczewski; William S Blaner
Journal:  Biochemistry       Date:  2007-03-23       Impact factor: 3.162

7.  Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses.

Authors:  Daniel C Berry; Hui Jin; Avijit Majumdar; Noa Noy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-23       Impact factor: 11.205

8.  Reply to "How free retinol behaves differently from RBP-bound retinol in RBP receptor-mediated vitamin A uptake".

Authors:  Noa Noy
Journal:  Mol Cell Biol       Date:  2014-06       Impact factor: 4.272

9.  Signaling by retinol and its serum binding protein.

Authors:  Noa Noy
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-10-29       Impact factor: 4.006

10.  Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease.

Authors:  Christopher L Cioffi; Nicoleta Dobri; Emily E Freeman; Michael P Conlon; Ping Chen; Douglas G Stafford; Daniel M C Schwarz; Kathy C Golden; Lei Zhu; Douglas B Kitchen; Keith D Barnes; Boglarka Racz; Qiong Qin; Enrique Michelotti; Charles L Cywin; William H Martin; Paul G Pearson; Graham Johnson; Konstantin Petrukhin
Journal:  J Med Chem       Date:  2014-09-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.